gip glp 1 drugs Targeting GLP-1, & GCG in Obesity and Type 2 Diabetes Research GLP-1 receptor agonists review and
Description
Hausner, H., Derving Karsbl, J., Holst, A
However, despite these advantages, the clinical use of native GLP-1 is significantly limited by its short plasma half-life (12 min), owing to rapid enzymatic degradation by DPP-4 and renal clearance
These findings highlight the importance of optimizing escalation protocols in future studies
It means your nutrition strategy needs to be more intentional while taking them
doi: 10.1016/j.bone.2019.05.014 21 AsmarMSimonsenLArngrimNHolstJJDelaFBlowJ
